Invention Grant
- Patent Title: OCT-enabled injection for vitreoretinal surgery
-
Application No.: US16150803Application Date: 2018-10-03
-
Publication No.: US10993614B2Publication Date: 2021-05-04
- Inventor: Steven T. Charles
- Applicant: NOVARTIS AG
- Applicant Address: CH Basel
- Assignee: NOVARTIS AG
- Current Assignee: NOVARTIS AG
- Current Assignee Address: CH Basel
- Main IPC: A61B3/13
- IPC: A61B3/13 ; A61F9/007 ; A61B3/10 ; A61B3/12 ; A61B90/00 ; A61B90/20 ; A61B3/00 ; A61B5/00 ; A61B34/20 ; A61B17/00
Abstract:
OCT-enabled injection for vitreoretinal surgery may involve using an OCT image to detect when a surgical injector penetrates a desired tissue layer of the eye for receiving an injection. The injection may be triggered or automatically actuated based on the detection of the surgical injector from the OCT image.
Public/Granted literature
- US20190110682A1 OCT-ENABLED INJECTION FOR VITREORETINAL SURGERY Public/Granted day:2019-04-18
Information query
